Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming Group N.V (PHAR) Long-Term Investments: 2019-2025

Historic Long-Term Investments for Pharming Group N.V (PHAR) over the last 5 years, with Sep 2025 value amounting to $1.0 million.

  • Pharming Group N.V's Long-Term Investments fell 1.08% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 1.08%. This contributed to the annual value of $466,000 for FY2024, which is 79.61% down from last year.
  • Per Pharming Group N.V's latest filing, its Long-Term Investments stood at $1.0 million for Q3 2025, which was down 0.10% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, Pharming Group N.V's Long-Term Investments ranged from a high of $7.6 million in Q2 2022 and a low of $2,845 during Q3 2022.
  • For the 3-year period, Pharming Group N.V's Long-Term Investments averaged around $1.4 million, with its median value being $1.4 million (2024).
  • Within the past 5 years, the most significant YoY rise in Pharming Group N.V's Long-Term Investments was 95,943.47% (2022), while the steepest drop was 99.96% (2022).
  • Over the past 5 years, Pharming Group N.V's Long-Term Investments (Quarterly) stood at $7.2 million in 2021, then slumped by 65.27% to $2.5 million in 2022, then declined by 8.64% to $2.3 million in 2023, then crashed by 79.61% to $466,000 in 2024, then declined by 1.08% to $1.0 million in 2025.
  • Its Long-Term Investments stands at $1.0 million for Q3 2025, versus $1.0 million for Q2 2025 and $672,000 for Q1 2025.